Status:
COMPLETED
Mesotherapy Versus Systemic Therapyin Treatment of Migraine Headache
Lead Sponsor:
Ataturk University
Conditions:
Migraine Headache
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Introduction:Migraine is a prevalent disabling primary headache disorder which is classified in two major types; migraine without aura and migraine with aura. The aim of this study was to compare the ...
Eligibility Criteria
Inclusion
- 18 years and older age, and (2)
- Admission to Emergency Department (ED) with headache related to the migraine without aura.
Exclusion
- Taking analgesic drugs before admission,
- Having VAS score of lower than 4 on admission,
- Having diabetes mellitus,
- Body mass index\>30 kg/m2,
- Pregnancy,
- Lactation,
- Having active bleeding or bleeding disorder,
- Having active or recurrent gastrointestinal hemorrhage or ulcer, or history of these conditions,
- Having a serious or life-threatening condition (stroke, intracranial hemorrhage, heart attack, cardiac tamponade, pneumothorax, hemothorax, flail chest, etc.).
Key Trial Info
Start Date :
December 1 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 1 2020
Estimated Enrollment :
150 Patients enrolled
Trial Details
Trial ID
NCT04519346
Start Date
December 1 2019
End Date
May 1 2020
Last Update
August 19 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ataturk University
Erzurum, Turkey (Türkiye)